Nerve Block Articles & Analysis
14 news found
Overall, dexmedetomidine hydrochloride can be used for general anaesthesia, local anaesthesia, spinal anaesthesia, and nerve-blocking anaesthesia in clinical operations. The Marketing Chief of Alfa Chemistry said: “As a chemical supplier, we are specialized in providing dexmedetomidine hydrochloride as raw APIs for researchers across the ...
A medial branch block is similar to a nerve block, except that the medication used is injected outside of the joint and closer to the nerves. ...
Neuros Medical, Inc., a medical device company developing an innovative, on-demand bioelectric nerve block therapy for patients with intractable post-amputation pain, announced today the completion of its QUEST Pivotal Trial 90-day primary endpoints. ...
During the two days, Medovate will introduce attendees to examples of the SAFIRA® system on their stand enabling them to witness first-hand how the system works and the benefits it provides for safer peripheral nerve blocks. SAFIRA® has been developed by medical device company Medovate in collaboration with clinicians from the UK’s National Health ...
ByMedovate
This revolutionary new system for regional anaesthesia has been developed in partnership with clinicians from The Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust in the United Kingdom. Mitigating for nerve damage during regional anaesthesia through innovation The concept for the SAFIRA® system was born from observations made on the clinical front line with ...
ByMedovate
” Developed with clinicians working in the UK’s NHS to promote safer injection during single shot regional anesthesia peripheral nerve block procedures, the SAFIRA® system transforms regional anesthesia into a one-person procedure, giving the anesthesiologist full control of the injection at all times. It also includes a built-in safety mechanism ...
ByMedovate
Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, announced today the completion of enrollment in its pivotal QUEST (High-FreQUEncy Nerve Block for PoST-Amputation Pain) study. ...
“Emergency medicine will become so much more precise, swift, patient-focused and outcome-oriented as physicians are educated and empowered by intuitive handheld ultrasound devices that are at the ready for everything from traumatic injury diagnosis to nerve-block procedures.” Whether pinpointing veins for IVs, evaluating cardiological conditions or ...
ByExo
Food and Drug Administration (FDA) for the use of its novel High-Frequency Nerve Block system as an aid in the management of chronic intractable pain of the lower limb of adult amputees. ...
Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, announced today the achievement of two milestones in its pivotal QUEST (High-FreQUEncy Nerve Block for PoST-Amputation Pain) study. ...
Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, announced today the close of a Series BB financing totaling $38.5 million. ...
This technique is of particular interest when performing procedures under local anesthesia, such as peripheral nerve blocks, epidural and spinal ...
“Neuros Medical, with its patented Altius® System High Frequency Nerve Block technology, has the opportunity to develop important therapy options for patients who experience significant pain as a result of a number of disease conditions,” said Mr. ...
“We will utilize these funds to complete our initial pivotal IDE clinical study, which is evaluating the use of our patented Altius® System High Frequency Nerve Block technology for the man agement of post-amputation pain, and, ultimately, to secure Pre-Market Approval (PMA) from the Food & Drug Administration (FDA) . ...